I believe it is called the cardiac muscle.
Answer:
The correct answer is DNA or RNA. Viral chromosomes exist in a variety of conformations and can be made up of <u>DNA or RNA</u>
Explanation:
The hereditary material of viruses is organized into chromosomes of different types. From the genetic point of view, viruses can be classified into DNA or RNA viruses, double helix or single helix, and circular or linear, that is, viral chromosomes are linear or circular molecules of DNA or RNA. Viruses can be classified according to the type of organism they parasitize in: Bacteriophages or phages, animal viruses and plant-type viruses. Viral chromosomes are also subject to the recombination process, this happens when an individual cell is infected simultaneously by two mutant strains of a virus.
Answer: a, to avoid overgrazing, vegetation loss and soil erosion
Explanation: I just finished the assignment and it was correct
Answer:
Apoptosis of the infected cell.
Explanation:
Lytic and lysogenic are the two different types of viral life cycle. In the lysogenic part of life cycle the virus remain in the latent stage. In this stage, the genetic material of the virus gets attached with the host genetic material and gets replicated with the host genome. This stage is called prophase stage.
In lytic part, the viral gene transcribe and produce viral protein from which new phage particles are formed which do apoptosis of cell and gets released from the cell to infect other cells. So to be able to remain latent in the infected live cell HSV virus should shut down the apoptosis process of the infected cells.
Stem cell therapies are not new. Doctors have been performing bone marrow stem cell transplants for decades. But when scientists learned how to remove stem cells from human embryos in 1998, both excitement and controversy ensued.
The excitement was due to the huge potential these cells have in curing human disease. The controversy centered on the moral implications of destroying human embryos. Political leaders began to debate over how to regulate and fund research involving human embryonic stem (hES) cells.
Newer breakthroughs may bring this debate to an end. In 2006 scientists learned how to stimulate a patient's own cells to behave like embryonic stem cells. These cells are reducing the need for human embryos in research and opening up exciting new possibilities for stem cell therapies.
